<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Australia</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Australia.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/au.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Hearing aids for mild to moderate hearing loss in adults</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd012023-pub3-623f5813/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd012023-pub3-623f5813/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>Findings align with routine first-line clinical provision of hearing aids to adults seeking help for hearing difficulties, while signalling ongoing uncertainty around benefits for mental health and cognition.</description>
    <category>AIDS</category>
    <category>Noise-induced hearing loss</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Report of the National Influenza Surveillance Scheme, 2019</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-33321-cdi-2026-50-020-ab952e89/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-33321-cdi-2026-50-020-ab952e89/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The report highlights a high hospital burden from confirmed influenza admissions, alongside moderate severity as indicated by intensive care unit admission proportions, and very low influenza-attributed mortality.</description>
    <category>Influenza</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Report of the National Influenza Surveillance Scheme, 2020–2021</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-33321-cdi-2026-50-021-5d1ab8a5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-33321-cdi-2026-50-021-5d1ab8a5/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The report documents an unprecedented two-year suppression of influenza activity in Australia concurrent with COVID-19 PHSMs, providing a descriptive baseline relevant to understanding how non-pharmaceutical measures and pandemic-era conditions can shape seasonal influenza epidemiology.</description>
    <category>Influenza</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Do Digital Visual Aids Improve Skin Self-Examination Behaviours? A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1177-10901981261479324-f115e091/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1177-10901981261479324-f115e091/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>Skin self-examination represents a secondary prevention approach for early skin cancer detection. Digital visual aids such as smartphone applications may support broader uptake and maintenance of these examination behaviors.</description>
    <category>AIDS</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Melioidosis in South Asia: Scientific Advances, Regional Challenges and One Health Perspectives—An Integrated Research Synthesis from the 4th South Asian Melioidosis Congress</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-12688-wellcomeopenres-27378-1-ded6c4b1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-12688-wellcomeopenres-27378-1-ded6c4b1/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The compilation frames melioidosis as an escalating yet frequently ignored infectious threat that demands improved monitoring frameworks, uniform testing standards, and interdisciplinary coordination to decrease adverse health outcomes.</description>
    <category>Melioidosis</category>
    <category>Tuberculosis</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Antimicrobial resistance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Australian adults&apos; views on influenza vaccination: Implications for communication and service quality from a qualitative study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128846-d9886d88/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128846-d9886d88/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Immunization programs may achieve higher enrollment by aligning educational campaigns with accessible, patient-focused service models.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety and immunogenicity of a genetically inactivated stand-alone acellular pertussis vaccine as a booster to Australian adults: a randomized, controlled, non-inferiority trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128863-a285187d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128863-a285187d/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Waning immunity following acellular pertussis vaccination has been observed in pertussis outbreaks, creating a need for more effective acellular pertussis vaccines. The findings support the potential use of this 2-component vaccine as a pertussis booster in adults.</description>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Australians&apos; attitudes to mRNA vaccination in humans and animals: A cross-sectional survey</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128907-dee036dc/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128907-dee036dc/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors highlight the need for vaccine manufacturers and public- and animal-health policymakers to anticipate potentially lower public acceptance of mRNA vaccines and of animal-source foods derived from mRNA-vaccinated livestock, noting that scientific development must be matched by public acceptability for new vaccines to be optimally used.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Diphtheria outbreak, Northern Territory of Australia, 2025 to 2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-23-2600443-05bbfb72/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-23-2600443-05bbfb72/</guid>
    <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
    <description>The event demonstrates that sustained immunization programs can be circumvented by specific socioeconomic and environmental risk factors, necessitating targeted monitoring of cutaneous manifestations.</description>
    <category>Diphtheria</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Genomic epidemiology</category>
    <category>Transmission dynamics</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Ecological suitability of Japanese encephalitis virus in Australia: A modelling analysis of vector-host transmission dynamics to potential spillover in humans</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013722-b8a39c4e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013722-b8a39c4e/</guid>
    <pubDate>Mon, 17 Nov 2025 00:00:00 GMT</pubDate>
    <description>The findings identify geographic areas where the model estimates greater ecological suitability and conditional potential for human spillover. The authors state that the results may inform targeted surveillance and vector control planning, but the supplied evidence does not establish an ongoing or current transmission signal.</description>
    <category>Japanese Encephalitis</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Selecting candidate Neisseria gonorrhoeae strains for oropharyngeal gonorrhoea human challenge: a genomics-based analysis of clinical isolates</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2025-101105-dd3c0aac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2025-101105-dd3c0aac/</guid>
    <pubDate>Mon, 01 Sep 2025 00:00:00 GMT</pubDate>
    <description>The work supports development of a controlled human infection model that could accelerate novel gonorrhoea prevention and therapeutic strategies, addressing a pathogen of major public health concern due to rising prevalence and antimicrobial resistance. The selection approach prioritizes participant safety and identifies strains relevant for evaluating current and future vaccines.</description>
    <category>Gonorrhea</category>
    <category>Gonococcal infection</category>
    <category>Antimicrobial resistance</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Diverse diagnostic and management approaches for acute rheumatic fever in Australia and New Zealand: findings of a prospective clinical study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjopen-2025-099827-90b6b044/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjopen-2025-099827-90b6b044/</guid>
    <pubDate>Thu, 17 Jul 2025 00:00:00 GMT</pubDate>
    <description>Documented discrepancies in clinical workflows and patient outcomes underscore the necessity for harmonized regional guidelines tailored to specific epidemiological contexts.</description>
    <category>Rheumatic fever</category>
    <category>Diagnostics</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Responding to avian influenza in poultry farms in Victoria, Australia.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-blt-24-292748-5d05f795/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-blt-24-292748-5d05f795/</guid>
    <pubDate>Tue, 27 May 2025 00:00:00 GMT</pubDate>
    <description>The publication underscores the necessity for enhanced interagency cooperation and expanded preventive healthcare access to manage future zoonotic spillover events effectively.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>H7N9</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-irv-70007-01fcf411/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-irv-70007-01fcf411/</guid>
    <pubDate>Wed, 25 Sep 2024 00:00:00 GMT</pubDate>
    <description>The article provides Queensland-specific evidence on influenza activity and vaccine effectiveness during a year when vaccination was publicly funded for all residents. It also reports outcome-specific and age-specific effectiveness estimates, including estimates for hospitalisation.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Whole genome sequencing of drug-resistant Mycobacterium tuberculosis isolates in Victoria, Australia</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2023-11-010-fa8cc9af/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2023-11-010-fa8cc9af/</guid>
    <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
    <description>The findings support the value of whole genome sequencing for identifying clusters and resistance mutations in low-burden settings, which can inform contact tracing, surveillance, and treatment strategies for drug-resistant TB.</description>
    <category>Tuberculosis</category>
    <category>Genomic epidemiology</category>
    <category>Transmission dynamics</category>
    <category>Antimicrobial resistance</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Rapid prototyping of models for COVID-19 outbreak detection in workplaces</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-023-08713-y-57000c0f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-023-08713-y-57000c0f/</guid>
    <pubDate>Mon, 23 Oct 2023 00:00:00 GMT</pubDate>
    <description>The work informs workplace testing policy in Australia by illustrating how surveillance design choices shape detectability of COVID-19 outbreaks in occupational settings.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>From program suspension to the pandemic: A qualitative examination of Australia’s vaccine pharmacovigilance system over 10 years</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2021-07-059-bee48e86/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2021-07-059-bee48e86/</guid>
    <pubDate>Wed, 01 Sep 2021 00:00:00 GMT</pubDate>
    <description>The findings address readiness for COVID-19 vaccine safety monitoring and identify opportunities to enhance pharmacovigilance systems that could contribute to both local and global vaccine safety surveillance. Transparent communication was emphasized as essential for addressing vaccine safety concerns during the pandemic.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Vaccine safety</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2020-25-47-2001847-08a38edb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2020-25-47-2001847-08a38edb/</guid>
    <pubDate>Thu, 26 Nov 2020 00:00:00 GMT</pubDate>
    <description>The findings suggest that movement restrictions within and into Australia may have temporarily eliminated influenza circulation, demonstrating the broader impact of COVID-19 control measures on respiratory disease epidemiology.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>SARS</category>
    <category>Surveillance</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0008659-b164e23b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0008659-b164e23b/</guid>
    <pubDate>Mon, 28 Sep 2020 00:00:00 GMT</pubDate>
    <description>The findings are relevant to hospital treatment policy and guideline maintenance for melioidosis in tropical settings.</description>
    <category>Melioidosis</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Intense interseasonal influenza outbreaks, Australia, 2018/19</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2019-24-33-1900421-27c620d3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2019-24-33-1900421-27c620d3/</guid>
    <pubDate>Thu, 15 Aug 2019 00:00:00 GMT</pubDate>
    <description>These unprecedented interseasonal outbreaks followed a mild 2018 influenza season and highlight the need for year-round influenza surveillance even in temperate climates with strong seasonal patterns. The event underscores that interseasonal influenza activity can reach levels comparable to or exceeding typical seasonal peaks.</description>
    <category>Influenza</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>El Niño Southern Oscillation, overseas arrivals and imported chikungunya cases in Australia: A time series analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0007376-b2614eac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0007376-b2614eac/</guid>
    <pubDate>Mon, 20 May 2019 00:00:00 GMT</pubDate>
    <description>Findings are relevant for anticipating periods of higher importation risk and considering climatic drivers of overseas chikungunya activity when planning Australian preparedness, given the presence of suitable local vectors.</description>
    <category>Chikungunya</category>
    <category>Travel medicine</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Use of Whole-Genome Sequencing to Link Burkholderia pseudomallei from Air Sampling to Mediastinal Melioidosis, Australia</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2111-141802-05ef0fd0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2111-141802-05ef0fd0/</guid>
    <pubDate>Sun, 01 Nov 2015 00:00:00 GMT</pubDate>
    <description>The report is relevant to transmission investigations for melioidosis because it describes environmental sampling paired with genomic comparison in a suspected inhalational case. It may help contextualize how environmental sources are studied in relation to human infection, without establishing broader frequency or surveillance patterns.</description>
    <category>Melioidosis</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Climate and environment</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Global epidemiology of meningococcal disease</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2009-04-063-92a6a7dd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2009-04-063-92a6a7dd/</guid>
    <pubDate>Mon, 01 Jun 2009 00:00:00 GMT</pubDate>
    <description>Surveillance data are essential for vaccine formulation, vaccination policy decisions, and monitoring vaccine impact. The dynamic and regionally variable epidemiology of meningococcal disease necessitates ongoing surveillance to guide public health interventions.</description>
    <category>Meningococcal disease</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
